Star Combo Pharma Limited provided an update on the existing site expansion and the recent approval on the adjacent 165 Woodpark Road in Smithfield, New South Wales. Star Combo has received approval for its Development Application from Cumberland City Council to begin works at its site at 165 Woodpark Road, Smithfield. The site was purchased in August last year and the development project of this new multi-level complex will accommodate a modern, purpose-built R&D and Test Laboratory Centre. The development project supports Star Combo's strategy to become a leading contract manufacturer in Australia's premium vitamins and dietary supplements sector. Star Combo has re-commenced the expansion of its current facilities at its TGA-licensed nutraceutical manufacturing site at 171 Woodpark Road, Smithfield after works were put on hold in July due to the COVID-19 pandemic restrictions. Expansion plans underway at this site involve upgrading the existing facility and installation of 13 new production lines. Once complete, the upgraded site is expected to significantly increase production capacity and will enable Star Combo to cost effectively address the growing demand in both local and overseas markets for Australian made premium vitamins and dietary supplements. $3.4M has been invested to date and the facilities are on track to be completed in 2022 despite the delays caused by the pandemic.